EM
Eliana Merle UBS Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Altimmune
ALT
$334M
| $3.78 | $24 |
535%
upside
| Buy | 23 days ago |
|
2
Madrigal Pharmaceuticals
MDGL
$9.65B
| $433.15 | $523 |
21%
upside
| Buy | 24 days ago |
|
3
AnaptysBio
ANAB
$612M
| $21.89 | $20 |
9%
downside
| Neutral | 24 days ago |
|
4
Ascendis Pharma
ASND
$12.5B
| $205.91 | $307 |
49%
upside
| Buy | 28 days ago |
|
5
BioMarin Pharmaceuticals
BMRN
$11.1B
| $57.77 | $114 |
97%
upside
| Buy | 1 month ago |
|
6
Alnylam Pharmaceuticals
ALNY
$59.2B
| $451.99 | $550 |
22%
upside
| Buy | 1 month ago |
|
7
Sarepta Therapeutics
SRPT
$1.96B
| $18.71 | $12 |
36%
downside
| Neutral | 1 month ago |
|
8
ProKidney
PROK
$304M
| $2.25 | $8 |
256%
upside
| Buy | 1 month ago |
|
9
CureVac
CVAC
$1.21B
| $5.39 | $5.50 |
2%
upside
| Neutral | 2 months ago |
|
10
Arvinas
ARVN
$574M
| $7.82 | $21 |
169%
upside
| Buy | 3 months ago |
|
11
Kymera Therapeutics
KYMR
$3.11B
| $43.53 | $70 |
61%
upside
| Buy | 3 months ago |
|
12
Moderna
MRNA
$9.78B
| $25.13 | $70 |
179%
upside
| Buy | 4 months ago |
|
13
BridgeBio Pharma
BBIO
$10.2B
| $53.45 | $72 |
35%
upside
| Buy | 4 months ago |
|
14
Apellis Pharmaceuticals
APLS
$3.55B
| $28.13 | $44 |
56%
upside
| Overweight | 4 months ago |
|
15
89bio
ETNB
$1.32B
| $8.87 | $38 |
328%
upside
| Buy | 7 months ago |
|
16
Akero Therapeutics
AKRO
$3.58B
| $44.71 | $109 |
144%
upside
| Buy | 7 months ago |
|
17
Revolution Medicines
RVMD
$7.57B
| $40.51 | $71 |
75%
upside
| Buy | 8 months ago |
|
18
Tyra Biosciences
TYRA
$675M
| $12.66 | $28 |
121%
upside
| Buy | 8 months ago |
|
|
IVA
19
Inventiva
IVA
$775M
| $5.57 | $3 |
46%
downside
| Neutral | 9 months ago |
|
20
BioNTech
BNTX
$27B
| $112.44 | $131 |
17%
upside
| Neutral | 11 months ago |
|
|
21
Apellis Pharmaceuticals
APLS
$3.55B
| $28.13 | $83 |
195%
upside
| Buy | 1 year ago |
|
22
Kodiak Sciences
KOD
$557M
| $10.54 | $5 |
53%
downside
| Neutral | 1 year ago |
|
23
Terns Pharmaceuticals
TERN
$631M
| $7.21 | $18 |
150%
upside
| Buy | 1 year ago |
|
24
uniQure
QURE
$986M
| $17.97 | $42 |
134%
upside
| Buy | 2 years ago |
|
25
Gossamer Bio
GOSS
$668M
| $2.94 | $8 |
172%
upside
| Buy | 2 years ago |
|